• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2004年美国与27个欧洲国家门诊全身用抗菌药物使用情况比较。

Comparison of outpatient systemic antibacterial use in 2004 in the United States and 27 European countries.

作者信息

Goossens Herman, Ferech Matus, Coenen Samuel, Stephens Peter

机构信息

University of Antwerp, Antwerp, Belgium.

出版信息

Clin Infect Dis. 2007 Apr 15;44(8):1091-5. doi: 10.1086/512810. Epub 2007 Mar 2.

DOI:10.1086/512810
PMID:17366456
Abstract

The European Surveillance of Antimicrobial Consumption (ESAC) project collects data on antibacterial use in Europe, applying the Anatomic Therapeutic Chemical classification system and defined daily dose methodology, as recommended by the World Health Organization. Comparable data for the United States have been collected from IMS Health. The IMS Health sales data, processed according to ESAC methodology, suggest that outpatient antibacterial use in the United States is high (only 3 of 27 European countries used more) and is mainly characterized by a shift towards newer antibiotics.

摘要

欧洲抗菌药物消费监测(ESAC)项目按照世界卫生组织的建议,运用解剖治疗化学分类系统和限定日剂量方法,收集欧洲抗菌药物使用的数据。美国的可比数据则来自艾美仕市场研究公司(IMS Health)。根据ESAC方法处理的IMS Health销售数据表明,美国门诊抗菌药物的使用量很高(27个欧洲国家中只有3个国家的使用量更高),并且主要特点是向新型抗生素转变。

相似文献

1
Comparison of outpatient systemic antibacterial use in 2004 in the United States and 27 European countries.2004年美国与27个欧洲国家门诊全身用抗菌药物使用情况比较。
Clin Infect Dis. 2007 Apr 15;44(8):1091-5. doi: 10.1086/512810. Epub 2007 Mar 2.
2
European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in Europe.欧洲抗菌药物消费监测(ESAC):欧洲门诊抗生素使用情况
J Antimicrob Chemother. 2006 Aug;58(2):401-7. doi: 10.1093/jac/dkl188. Epub 2006 May 30.
3
European Surveillance of Antimicrobial Consumption (ESAC): outpatient parenteral antibiotic treatment in Europe.欧洲抗菌药物消费监测(ESAC):欧洲门诊胃肠外抗生素治疗
J Antimicrob Chemother. 2009 Jul;64(1):200-5. doi: 10.1093/jac/dkp135. Epub 2009 Apr 21.
4
European Surveillance of Antimicrobial Consumption (ESAC): outpatient macrolide, lincosamide and streptogramin (MLS) use in Europe.欧洲抗菌药物消费监测(ESAC):欧洲门诊大环内酯类、林可酰胺类及链阳菌素类(MLS)药物的使用情况
J Antimicrob Chemother. 2006 Aug;58(2):418-22. doi: 10.1093/jac/dkl184. Epub 2006 May 30.
5
European Surveillance of Antimicrobial Consumption (ESAC): outpatient penicillin use in Europe.欧洲抗菌药物消费监测(ESAC):欧洲门诊青霉素使用情况
J Antimicrob Chemother. 2006 Aug;58(2):408-12. doi: 10.1093/jac/dkl186. Epub 2006 May 30.
6
European Surveillance of Antimicrobial Consumption (ESAC): outpatient cephalosporin use in Europe.欧洲抗菌药物消费监测(ESAC):欧洲门诊头孢菌素的使用情况
J Antimicrob Chemother. 2006 Aug;58(2):413-7. doi: 10.1093/jac/dkl185. Epub 2006 May 30.
7
European Surveillance of Antimicrobial Consumption (ESAC): outpatient quinolone use in Europe.欧洲抗菌药物消费监测(ESAC):欧洲门诊喹诺酮类药物的使用情况
J Antimicrob Chemother. 2006 Aug;58(2):423-7. doi: 10.1093/jac/dkl183. Epub 2006 May 30.
8
European Surveillance of Antimicrobial Consumption (ESAC): outpatient macrolide, lincosamide and streptogramin (MLS) use in Europe (1997-2009).欧洲抗菌药物消耗监测网(ESAC):1997-2009 年欧洲门诊大环内酯类、林可酰胺类和链阳菌素类(MLS)药物使用情况。
J Antimicrob Chemother. 2011 Dec;66 Suppl 6:vi37-45. doi: 10.1093/jac/dkr456.
9
European Surveillance of Antimicrobial Consumption (ESAC): outpatient cephalosporin use in Europe (1997-2009).欧洲抗菌药物消耗监测(ESAC):欧洲门诊头孢菌素使用情况(1997-2009 年)。
J Antimicrob Chemother. 2011 Dec;66 Suppl 6:vi25-35. doi: 10.1093/jac/dkr455.
10
European Surveillance of Antimicrobial Consumption (ESAC): outpatient penicillin use in Europe (1997-2009).欧洲抗菌药物消耗监测(ESAC):欧洲门诊青霉素使用情况(1997-2009 年)。
J Antimicrob Chemother. 2011 Dec;66 Suppl 6:vi13-23. doi: 10.1093/jac/dkr454.

引用本文的文献

1
Four recent insights suggest the need for more refined methods to assess the resistogenicity of doxycycline post exposure prophylaxis.最近的四项见解表明,需要更精细的方法来评估暴露后预防中多西环素的抗生性。
Curr Res Microb Sci. 2024 Apr 8;6:100234. doi: 10.1016/j.crmicr.2024.100234. eCollection 2024.
2
Decreases and Pronounced Geographic Variability in Antibiotic Prescribing in Medicaid.医疗补助计划中抗生素处方量的减少及显著的地区差异
Pharmacy (Basel). 2024 Mar 1;12(2):46. doi: 10.3390/pharmacy12020046.
3
Reduction strategies for inpatient oral third-generation cephalosporins at a cancer center: An interrupted time-series analysis.
癌症中心住院患者口服第三代头孢菌素的减少策略:一项中断时间序列分析。
PLoS One. 2023 Feb 9;18(2):e0281518. doi: 10.1371/journal.pone.0281518. eCollection 2023.
4
Poly Lactic-Co-Glycolic Acid Nano-Carriers for Encapsulation and Controlled Release of Hydrophobic Drug to Enhance the Bioavailability and Antimicrobial Properties.用于封装和控释疏水性药物以提高生物利用度和抗菌性能的聚乳酸-乙醇酸纳米载体
Dose Response. 2023 Jan 30;21(1):15593258231152117. doi: 10.1177/15593258231152117. eCollection 2023 Jan-Mar.
5
Impact of targeted intervention using a collaborative approach for oral third-generation cephalosporins: An interrupted time-series analysis.采用协作方法对口服第三代头孢菌素进行靶向干预的影响:一项中断时间序列分析。
Antimicrob Steward Healthc Epidemiol. 2022 Jul 11;2(1):e115. doi: 10.1017/ash.2022.251. eCollection 2022.
6
The consequence of financial incentives for not prescribing antibiotics: a Japan's nationwide quasi-experiment.不处方抗生素的经济激励后果:日本全国准实验。
Int J Epidemiol. 2022 Oct 13;51(5):1645-1655. doi: 10.1093/ije/dyac057.
7
Unraveling the role of the microbiome in chronic rhinosinusitis.揭开微生物组在慢性鼻-鼻窦炎中的作用。
J Allergy Clin Immunol. 2022 May;149(5):1513-1521. doi: 10.1016/j.jaci.2022.02.022. Epub 2022 Mar 14.
8
Risk factors, diagnosis, and treatment of peri-implantitis: A cross-cultural comparison of U.S. and European periodontists' considerations.种植体周围炎的危险因素、诊断与治疗:美国和欧洲牙周病学家考虑因素的跨文化比较。
J Periodontol. 2022 Apr;93(4):481-492. doi: 10.1002/JPER.21-0010. Epub 2021 Oct 19.
9
Consumption of macrolides, lincosamides and streptogramins in the community, European Union/European Economic Area, 1997-2017.社区大环内酯类、林可酰胺类和链阳菌素类药物的消费情况,1997-2017 年,欧盟/欧洲经济区。
J Antimicrob Chemother. 2021 Jul 26;76(12 Suppl 2):ii30-ii36. doi: 10.1093/jac/dkab175.
10
Increase and Change in the Pattern of Antibiotic Use in Serbia (2010-2019).塞尔维亚抗生素使用模式的增加与变化(2010 - 2019年)
Antibiotics (Basel). 2021 Apr 7;10(4):397. doi: 10.3390/antibiotics10040397.